Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Bays

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 5, 2014
Single-pill combination of telmisartan and hydrochlorothiazide: studies and pooled analyses of earlier hypertension treatmentHarold Bays, Dingliang Zhu, Helmut Schumacher
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approachHarold Bays, Lawrence Mandarino, Ralph A DeFronzo
Diabetes & Vascular Disease Research|October 2, 2007
A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitusHarold Bays, Jennifer McElhattan, Brian S Bryzinski, et al.
Journal of Clinical Lipidology|May 6, 2014
JCL roundtable: Clinical management of individuals with obesityW Virgil Brown, Harold Bays, George A Bray
The American Journal of Cardiology|June 5, 2004
Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndromePrakash C Deedwania, Donald B Hunninghake, Harold Bays
Journal of Clinical Lipidology|March 12, 2011
Drugs in development for management of lipoprotein disordersW Virgil Brown, Harold Bays, Michael Davidson, et al.
Journal of Clinical Lipidology|November 24, 2011
Using omega-3 fatty acids in the practice of clinical lipidologyW Virgil Brown, Harold Bays, William Harris, et al.
Drugs & Aging|August 6, 2014
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibePhilip Schwab, Anthony Louder, Yong Li, et al.
Journal of Clinical Lipidology|September 29, 2016
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patientsEvan Stein, Harold Bays, Michael Koren, et al.
Current Medical Research and Opinion|November 2, 2006
Lipid-lowering effects of colesevelam HCl in combination with ezetimibeHarold Bays, James Rhyne, Stacey Abby, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|February 5, 2014
Single-pill combination of telmisartan and hydrochlorothiazide: studies and pooled analyses of earlier hypertension treatmentHarold Bays, Dingliang Zhu, Helmut Schumacher
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approachHarold Bays, Lawrence Mandarino, Ralph A DeFronzo
Diabetes & Vascular Disease Research|October 2, 2007
A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitusHarold Bays, Jennifer McElhattan, Brian S Bryzinski, et al.
Journal of Clinical Lipidology|May 6, 2014
JCL roundtable: Clinical management of individuals with obesityW Virgil Brown, Harold Bays, George A Bray
The American Journal of Cardiology|June 5, 2004
Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndromePrakash C Deedwania, Donald B Hunninghake, Harold Bays
Journal of Clinical Lipidology|March 12, 2011
Drugs in development for management of lipoprotein disordersW Virgil Brown, Harold Bays, Michael Davidson, et al.
Journal of Clinical Lipidology|November 24, 2011
Using omega-3 fatty acids in the practice of clinical lipidologyW Virgil Brown, Harold Bays, William Harris, et al.
Drugs & Aging|August 6, 2014
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibePhilip Schwab, Anthony Louder, Yong Li, et al.
Journal of Clinical Lipidology|September 29, 2016
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patientsEvan Stein, Harold Bays, Michael Koren, et al.
Current Medical Research and Opinion|November 2, 2006
Lipid-lowering effects of colesevelam HCl in combination with ezetimibeHarold Bays, James Rhyne, Stacey Abby, et al.
Pageof 8